S-1/A: NYCB Files Amendment to S-1 Registration for Resale of Common Stock and Warrants

Sentiment:

S-1/A Filing


New York Community Bancorp (NYCB) has filed an amendment to its S-1 registration statement, allowing selling securityholders to offer and sell up to 280,000,000 shares of common stock and 315,000 warrants.

Capital raiseOn March 11, 2024, investors invested an aggregate of approximately $1.05 billion in the company in exchange for common stock, preferred stock, and warrants.

Summary

  • New York Community Bancorp, Inc. has filed an amendment to its Form S-1 registration statement with the SEC.
  • The filing relates to the potential offer and sale of up to 280,000,000 shares of common stock and 315,000 warrants by selling securityholders.
  • These securities were initially issued in a private placement on March 11, 2024, as part of a transaction where investors invested approximately $1.05 billion in the company.
  • The selling securityholders may sell the securities in various ways and at varying prices.
  • NYCB will not receive any proceeds from the sale of these securities by the selling securityholders.
  • The company's common stock is listed on the NYSE under the symbol NYCB, with a closing price of $10.41 per share on August 22, 2024.
  • The warrants are not currently listed on any national securities exchange, but the company intends to seek a listing.
  • The document highlights risk factors associated with investing in the securities, including potential fluctuations in the stock price and the impact of sales by selling securityholders.

Sentiment

Score: 5

Explanation: The document is primarily factual and descriptive, outlining the details of the registration statement and related transactions. While it highlights both positive and negative aspects, the overall tone is neutral. The inclusion of risk factors tempers any potential positive sentiment.

Positives

  • The registration allows selling securityholders to potentially realize gains on their investments.
  • The company is taking steps to list the warrants on a stock exchange, which could increase their liquidity.
  • The company has addressed concerns regarding beneficial ownership limitations by entering into share exchange agreements.

Negatives

  • The sale of a substantial number of shares by selling securityholders could depress the market price of NYCB's securities.
  • The warrants are speculative in nature and do not confer any rights of common stock ownership until exercised.
  • The company acknowledges material weaknesses in its internal controls over financial reporting, which could impact investor confidence.
  • The reverse stock split may decrease the liquidity of the company's common stock.

Risks

  • The price of NYCB's common stock may fluctuate significantly.
  • Sales of a substantial number of securities by selling securityholders could cause the price of the securities to fall.
  • The warrants are exercisable for shares of common stock, which will increase the number of shares eligible for future resale and result in dilution.
  • The company is in the process of remediating identified material weaknesses in its internal controls over financial reporting.
  • Recent negative developments affecting the banking industry may adversely affect the price of the company's common stock.

Future Outlook

The company has agreed to use its reasonable best efforts to procure and maintain the listing of the warrants, including the common stock underlying the warrants, on all stock exchanges on which the common stock is then listed or traded.

Industry Context

The document references recent high-profile collapses of certain U.S. banks, which have generated significant market volatility among publicly traded bank holding companies and, in particular, community and regional banks like NYCB. Concerns about commercial real estate concentrations at regional and community banks, including NYCB, have exacerbated this volatility.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Executive OfficerAlessandro P. DiNelloJoseph M. OttingApril 1, 2024Resignation
Executive Chairman of the board of directorsTBDJoseph M. OttingJune 5, 2024New appointment
Senior Executive Vice President and Chief Financial OfficerTBDCraig GiffordApril 12, 2024New appointment
Senior Executive Vice President, General Counsel and Chief of StaffTBDBao NguyenApril 12, 2024New appointment
Senior Executive Vice President and Head of Commercial Real Estate LendingTBDScott ShepherdApril 12, 2024New appointment

Related Party Transactions

  • On March 7, 2024, NYCB entered into Investment Agreements with Liberty, Hudson Bay, Reverence and the Other Investors.
  • Steven T. Mnuchin, one of the director representatives which Liberty has the right to nominate, is the Founder and Managing Partner of Liberty Strategic Capital.
  • Milton Berlinski, the Reverence director representative, is the Co-Founder of Reverence Capital Partners, L.P.
  • Additionally, on August 12, 2024, NYCB entered into the Exchange Agreements with Liberty, Hudson Bay and Reverence.

Stakeholder Impact

  • Shareholders may experience dilution if the warrants are exercised.
  • The market price of the common stock could be affected by sales from the selling securityholders.
  • Customers may be impacted by the company's ability to remediate material weaknesses in internal controls.

Next Steps

  • The selling securityholders may offer and sell the securities from time to time.
  • The company will use reasonable best efforts to list the warrants on a stock exchange.

Key Dates

DateDescription
March 7, 2024NYCB entered into investment agreements with investors.
March 11, 2024Private placement closed, investors invested approximately $1.05 billion.
June 5, 2024Stockholders approved amendments to the certificate of incorporation.
June 7, 2024COI Authorized Share Amendment became effective.
June 17, 2024Company paid a $0.01 per share dividend on its Common Stock.
July 11, 2024COI Reverse Stock Split Amendment became effective.
August 12, 2024Share exchange agreements entered into with Liberty, Hudson Bay, and Reverence.
August 22, 2024Closing price of NYCB common stock was $10.41 per share.
September 10, 2024Warrants become exercisable.
March 11, 2031Warrants expire.

Keywords

common stock, warrants, registration statement, selling securityholders, NYCB, reverse stock split, private placement, securities, investment, NYSE

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.